NCT02483624 3,3'-Diindolylmethane in Patients With Systemic Lupus Erythematosus Status TERMINATED Phase PHASE1
NCT02240888 Vaccination in Inflammatory Rheumatic Disease (VACCIMIL). The Impact of Antirheumatic Treatment on Antibody Response Status COMPLETED Phase NA
NCT01946880 Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE) Status TERMINATED Phase PHASE2
NCT01761422 Myocardial Inflammation in Systemic Lupus Erythematosus Status ACTIVE_NOT_RECRUITING Phase N/A
NCT01207297 Tacrolimus Versus Cyclophosphamide as Treatment for Lupus Nephritis Status COMPLETED Phase PHASE1
NCT01031797 QT Dispersion in Patients With Systemic Lupus Erythematosus (SLE) Status COMPLETED Phase N/A